Overview

D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
evaluation of the efficacy and safety of D-dimer adjusted heparin versus therapeutic dose heparin in patients with COVID-19 Pneumonia.
Phase:
Phase 4
Details
Lead Sponsor:
Ain Shams University
Treatments:
Dalteparin
Enoxaparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin